用于治疗眼部疾病的单克隆抗体
Cristina Henriques1,2, Raquel da Ana1, Karolline Krambeck2
1Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Journal of clinical medicine
|October 16, 2024
概括
单克隆抗体 (mAbs) 通过向特定抗原来彻底改变眼睛疾病的治疗方法. 本综述探讨了它们在眼科中的机制,益处和风险,用于诸如黄斑变性和脑膜炎等疾病.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 单克隆抗体 (mAbs) 是通过ADCC和CDC等向机制改变癌症治疗的生物药物.
- 最初开发用于瘤学,mAbs现在越来越多地用于治疗各种眼部疾病.
- 技术进步使得各种mAb类型的开发成为可能,包括嵌合体,人性化和全人类抗体.
研究的目的:
- 审查单克隆抗体 (mAbs) 在治疗眼部疾病中的当前应用.
- 讨论眼科中mAbs的特异性和多样化的治疗机制.
- 突出使用mAbs用于流行眼睛疾病的好处,缺点,有效性和风险.
主要方法:
- 对眼科中单克隆抗体应用的当前文献的综述.
- 分析mAb机制,包括抗原结合,免疫系统参与和癌细胞直接干扰.
- 专注于特定的眼部疾病,如与年龄相关的黄斑病,糖尿病视网膜病变和脑膜炎.
主要成果:
- 单克隆抗体在治疗各种眼部疾病方面显示出显著的治疗潜力.
- 人性化mAbs目前用于与年龄相关的黄斑疾病,糖尿病视网膜病变和脑膜炎等疾病.
- 目前正在进行的研究探索了mAbs的新应用,包括在SARS-CoV-2等病毒眼部感染中.
结论:
- 单克隆抗体代表了眼部疾病治疗的重大进步,提供了有针对性和有效的治疗选择.
- 该综述强调了了解mAb机制,益处和风险对于眼科患者最佳治疗结果的重要性.
- 在mAb技术的持续创新有望进一步扩大其在管理复杂的眼睛疾病和新出现的疾病的应用.
相关概念视频
Open Angle Glaucoma: Treatment
401
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
401
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
Angle Closure Glaucoma: Treatment
443
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
443
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


